ImageneBio Inc (IMA) vs Spectral AI, Inc. (MDAI)
A side-by-side comparison of ImageneBio Inc and Spectral AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMA
ImageneBio Inc
$4.76HealthcareDelayed quote: Oct 6, 2026, 12:31 PM EDT
MDAI
Spectral AI, Inc.
$1.70HealthcareDelayed quote: Oct 6, 2026, 12:38 PM EDT
Total return — IMA vs MDAI
growth of $100 · dividends reinvested · last 5yIMA -98.2% (-55.4%/yr)MDAI -82.6% (-29.5%/yr)MDAI compounded faster over this window
Log scale — wide-divergence pair
IMA MDAI
IMA vs MDAI: by the numbers
- •MDAI is the larger company ($54M vs $54M market cap).
- •Both run net losses; MDAI's is the smaller (-69.27% vs -5668.62% net margin).
Metrics side by side
Valuation
| Metric | IMA | MDAI |
|---|---|---|
| P/S ratio | N/A | 3.57 |
| P/B ratio | 0.38 | N/A |
Profitability
| Metric | IMA | MDAI |
|---|---|---|
| Gross margin | -29.12% | 41.51% |
| Operating margin | -6056.37% | -43.78% |
| Net margin | -5668.62% | -69.27% |
| ROE | -36.94% | N/A |
| ROIC | -40.53% | -353.68% |
Growth (annualized)
| Metric | IMA | MDAI |
|---|---|---|
| Total return CAGR (5Y) | -50.73% | -29.57% |
Frequently asked
- How have IMA and MDAI total returns compared?
- Over the past 5 years, IMA delivered -50.73% and MDAI delivered -29.57% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.